Is NAYA Biosciences, Stock a Good Investment?
NAYA Biosciences, Investment Advice | NAYA |
- Examine NAYA Biosciences,'s financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research NAYA Biosciences,'s leadership team and their track record. Good management can help NAYA Biosciences, navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Medical Equipment space and any emerging trends that could impact NAYA Biosciences,'s business and its evolving consumer preferences.
- Compare NAYA Biosciences,'s performance and market position to its competitors. Analyze how NAYA Biosciences, is positioned in terms of product offerings, innovation, and market share.
- Check if NAYA Biosciences, pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about NAYA Biosciences,'s stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in NAYA Biosciences, stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if NAYA Biosciences, is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine NAYA Biosciences, Stock
Researching NAYA Biosciences,'s stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 16.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.01. NAYA Biosciences, last dividend was issued on the 9th of November 2020. The entity had 1:20 split on the 28th of July 2023.
To determine if NAYA Biosciences, is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding NAYA Biosciences,'s research are outlined below:
| NAYA Biosciences, generated a negative expected return over the last 90 days | |
| NAYA Biosciences, has high historical volatility and very poor performance | |
| NAYA Biosciences, has some characteristics of a very speculative penny stock | |
| NAYA Biosciences, has a very high chance of going through financial distress in the upcoming years | |
| NAYA Biosciences, was previously known as INVO Old and was traded on NASDAQ Exchange under the symbol INVO. | |
| The company reported the previous year's revenue of 3.02 M. Net Loss for the year was (8.03 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NAYA Biosciences, generates negative cash flow from operations | |
| About 16.0% of the company outstanding shares are owned by corporate insiders |
NAYA Biosciences,'s market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.48 M.Basic technical analysis of NAYA Stock
As of the 27th of February, NAYA Biosciences, secures the mean deviation of 4.81, and Standard Deviation of 7.55. In respect to fundamental indicators, the technical analysis model lets you check practical technical drivers of NAYA Biosciences,, as well as the relationship between them.Understand NAYA Biosciences,'s technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing NAYA Biosciences,'s various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | 2.72 | |||
| Mean Deviation | 4.81 | |||
| Coefficient Of Variation | (587.31) | |||
| Standard Deviation | 7.55 | |||
| Variance | 56.96 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (1.30) | |||
| Total Risk Alpha | (1.23) | |||
| Treynor Ratio | 2.71 | |||
| Maximum Drawdown | 52.37 | |||
| Value At Risk | (9.30) | |||
| Potential Upside | 10.34 | |||
| Skewness | (1.42) | |||
| Kurtosis | 10.16 |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | 2.72 | |||
| Mean Deviation | 4.81 | |||
| Coefficient Of Variation | (587.31) | |||
| Standard Deviation | 7.55 | |||
| Variance | 56.96 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (1.30) | |||
| Total Risk Alpha | (1.23) | |||
| Treynor Ratio | 2.71 | |||
| Maximum Drawdown | 52.37 | |||
| Value At Risk | (9.30) | |||
| Potential Upside | 10.34 | |||
| Skewness | (1.42) | |||
| Kurtosis | 10.16 |
Consider NAYA Biosciences,'s intraday indicators
NAYA Biosciences, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NAYA Biosciences, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
NAYA Biosciences, time-series forecasting models is one of many NAYA Biosciences,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NAYA Biosciences,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
NAYA Stock media impact
Far too much social signal, news, headlines, and media speculation about NAYA Biosciences, that are available to investors today. That information is available publicly through NAYA media outlets and privately through word of mouth or via NAYA internal channels. However, regardless of the origin, that massive amount of NAYA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of NAYA Biosciences, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NAYA Biosciences, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NAYA Biosciences,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NAYA Biosciences, alpha.
When determining whether NAYA Biosciences, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NAYA Biosciences,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Naya Biosciences, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Naya Biosciences, Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NAYA Biosciences,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade NAYA Stock refer to our How to Trade NAYA Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NAYA Biosciences,. If investors know NAYA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NAYA Biosciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NAYA Biosciences, is measured differently than its book value, which is the value of NAYA that is recorded on the company's balance sheet. Investors also form their own opinion of NAYA Biosciences,'s value that differs from its market value or its book value, called intrinsic value, which is NAYA Biosciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NAYA Biosciences,'s market value can be influenced by many factors that don't directly affect NAYA Biosciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between NAYA Biosciences,'s value and its price, as these two are different measures arrived at by various means. Investors typically determine if NAYA Biosciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NAYA Biosciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.